Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
Orforglipron clinical trials
25 selected ClinicalTrials.gov records carrying the official matched intervention Orforglipron (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
25 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 7 selected PubMed records and 1 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT05869903
PeptideScanner retained ClinicalTrials.gov record NCT05869903 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-08-14, and PeptideScanner's reviewed identity mapping was orforglipron.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- August 14, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT05872620
PeptideScanner retained ClinicalTrials.gov record NCT05872620 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-09-04, and PeptideScanner's reviewed identity mapping was orforglipron.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- September 4, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT05931380
PeptideScanner retained ClinicalTrials.gov record NCT05931380 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-07-20, and PeptideScanner's reviewed identity mapping was orforglipron.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- July 20, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Orforglipron · 2026-11-05
ClinicalTrials.gov record NCT07794579
Recruiting at the retained observation.
Open attributed record →Orforglipron · 2026-11-04
ClinicalTrials.gov record NCT06672549
Recruiting at the retained observation.
Open attributed record →Orforglipron · 2026-11-04
ClinicalTrials.gov record NCT06672939
Recruiting at the retained observation.
Open attributed record →Orforglipron · 2026-11-04
ClinicalTrials.gov record NCT07202884
Recruiting at the retained observation.
Open attributed record →Orforglipron · 2026-11-04
ClinicalTrials.gov record NCT07223593
Recruiting at the retained observation.
Open attributed record →Orforglipron · 2026-11-04
ClinicalTrials.gov record NCT07241390
Recruiting at the retained observation.
Open attributed record →Orforglipron · 2026-10-16
ClinicalTrials.gov record NCT06192108
Completed at the retained observation.
Open attributed record →Orforglipron · 2026-10-13
ClinicalTrials.gov record NCT07790861
Not yet recruiting at the retained observation.
Open attributed record →Orforglipron · 2026-10-08
ClinicalTrials.gov record NCT07153471
Active, not recruiting at the retained observation.
Open attributed record →Orforglipron · 2026-10-08
ClinicalTrials.gov record NCT07613307
Recruiting at the retained observation.
Open attributed record →Orforglipron · 2026-10-01
ClinicalTrials.gov record NCT06109311
Completed at the retained observation.
Open attributed record →Orforglipron · 2026-09-14
ClinicalTrials.gov record NCT06649045
Completed at the retained observation.
Open attributed record →Orforglipron · 2026-09-04
ClinicalTrials.gov record NCT05872620
Completed at the retained observation.
Open attributed record →Orforglipron · 2026-09-03
ClinicalTrials.gov record NCT05971940
Completed at the retained observation.
Open attributed record →Orforglipron · 2026-08-31
ClinicalTrials.gov record NCT07739537
Not yet recruiting at the retained observation.
Open attributed record →Orforglipron · 2026-08-14
ClinicalTrials.gov record NCT05869903
Active, not recruiting at the retained observation.
Open attributed record →Orforglipron · 2026-07-31
ClinicalTrials.gov record NCT06993792
Active, not recruiting at the retained observation.
Open attributed record →Orforglipron · 2026-07-29
ClinicalTrials.gov record NCT06972459
Active, not recruiting at the retained observation.
Open attributed record →Orforglipron · 2026-07-27
ClinicalTrials.gov record NCT07729332
Not yet recruiting at the retained observation.
Open attributed record →Orforglipron · 2026-07-20
ClinicalTrials.gov record NCT05931380
Completed at the retained observation.
Open attributed record →Orforglipron · 2026-07-17
ClinicalTrials.gov record NCT06370728
Completed at the retained observation.
Open attributed record →Orforglipron · 2026-07-17
ClinicalTrials.gov record NCT06440980
Completed at the retained observation.
Open attributed record →Orforglipron · 2026-06-30
ClinicalTrials.gov record NCT06010004
Completed at the retained observation.
Open attributed record →Orforglipron · 2026-05-26
ClinicalTrials.gov record NCT06704763
Completed at the retained observation.
Open attributed record →Orforglipron · 2026-05-22
ClinicalTrials.gov record NCT06186622
Completed at the retained observation.
Open attributed record →